Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali

Clinical trial NCT04329104 · COMPLETED

Trial details

NCT number: NCT04329104
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plasmodium Falciparum Infection Malaria

Start date: 2021-02-15
Primary completion: 2022-01-26
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.